Page last updated: 2024-08-21

thiazoles and Blood Coagulation Disorders

thiazoles has been researched along with Blood Coagulation Disorders in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Alhamhoom, Y; Islam, N; Izake, EL; Mendhi, J; Muneer, S; Rashid, MA; Sabuj, MZR; Wang, T; Xiao, Y1
Dubois, J; Facundo, GB; Gavra, P; Kleiber, N; Lapointe, C; Remy, A; Théorêt, Y; Tran, TH; Winikoff, R1
Honda, Y; Ito, Y; Morishima, Y; Noguchi, K; Shibutani, T1
Fukuda, T; Furugohri, T; Kita, A; Morishima, Y; Shibano, T; Tsuji, N1
Fujiwara, T; Hashimoto, T; Horikoshi, H1
Dodd, K1

Reviews

1 review(s) available for thiazoles and Blood Coagulation Disorders

ArticleYear
Troglitazone and emerging glitazones: new avenues for potential therapeutic benefits beyond glycemic control.
    Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques, 2000, Volume: 54

    Topics: Animals; Arteriosclerosis; Blood Coagulation Disorders; Cardiac Output; Cholesterol; Chromans; Endothelium, Vascular; Fatty Acids, Nonesterified; Humans; Hypoglycemic Agents; Lipoproteins, LDL; Muscle, Smooth, Vascular; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone

2000

Other Studies

5 other study(ies) available for thiazoles and Blood Coagulation Disorders

ArticleYear
Inhaled Edoxaban dry powder inhaler formulations: Development, characterization and their effects on the coagulopathy associated with COVID-19 infection.
    International journal of pharmaceutics, 2021, Oct-25, Volume: 608

    Topics: Administration, Inhalation; Aerosols; Blood Coagulation Disorders; COVID-19; Dry Powder Inhalers; Humans; Particle Size; Powders; Pyridines; Thiazoles

2021
Repurposing alpelisib, an anti-cancer drug, for the treatment of severe TIE2-mutated venous malformations: Preliminary pharmacokinetics and pharmacodynamic data.
    Pediatric blood & cancer, 2022, Volume: 69, Issue:10

    Topics: Antineoplastic Agents; Blood Coagulation Disorders; Child; Drug Repositioning; Humans; Quality of Life; Thiazoles; Vascular Malformations

2022
Edoxaban, a direct oral factor Xa inhibitor, ameliorates coagulation, microvascular thrombus formation, and acute liver injury in a lipopolysaccharide-induced coagulopathy model in rats.
    Journal of thrombosis and thrombolysis, 2021, Volume: 52, Issue:1

    Topics: Animals; Blood Coagulation Disorders; Cytokines; Factor Xa Inhibitors; Lipopolysaccharides; Liver; Pyridines; Rats; Thiazoles; Thrombosis

2021
Melagatran, a direct thrombin inhibitor, but not edoxaban, a direct factor Xa inhibitor, nor heparin aggravates tissue factor-induced hypercoagulation in rats.
    European journal of pharmacology, 2012, Jul-05, Volume: 686, Issue:1-3

    Topics: Animals; Antithrombins; Azetidines; Benzylamines; Blood Coagulation Disorders; Factor Xa Inhibitors; Heparin; Male; Pyridines; Rats; Rats, Wistar; Thiazoles; Thromboplastin

2012
Angiostrongylus vasorum (Baillet, 1866) infestation in a greyhound kennels.
    The Veterinary record, 1973, Feb-24, Volume: 92, Issue:8

    Topics: Animals; Anthelmintics; Auscultation; Blood Coagulation Disorders; Dog Diseases; Dogs; Female; Larva; Lung; Male; Parasite Egg Count; Radiography; Thiazoles; Trichostrongyloidiasis

1973